Retatrutide – Advanced Hormonal Therapy for Sustainable Weight Loss

At Metamorphosis, we offer Retatrutide, a next-generation GLP-1, GIP, and glucagon receptor agonist that represents a significant leap forward in medical weight loss. This triple-action peptide works synergistically across multiple hormonal pathways to improve appetite control, fat metabolism, and energy expenditure—offering superior results compared to other GLP-1 therapies like Semaglutide or Tirzepitide.

Key benefits include:

• Average 24–30% weight loss, based on clinical trial outcomes

• Increased fat burning and preservation of lean muscle mass

• Enhanced insulin sensitivity and metabolic function

• Potential improvement in cardiovascular and metabolic conditions

By helping the body convert stored fat into usable energy and reducing hunger signals at the brain level, Retatrutide empowers patients to lose weight effectively and sustainably.

To begin therapy, recent blood work (within the last 3–6 months) is required. Outside lab work is accepted.

Transform your health with one of the most advanced weight-loss peptides available.